Wednesday, July 8, 2026

Patent intelligence · US

US 11911455

HPV therapeutic nucleic acid vaccine

granted A61KA61K2039/53A61K2039/55516A61K2039/572
Status granted
Linked drugs 1
Pipeline programs 6
Years to expiry 18
Applicant portfolio 9
Patent details — US 11911455
Jurisdiction
US
Status
granted
Grant date
Feb 27, 2024
Expiration
Feb 22, 2044
Claims
17
CPC classes
A61K, A61K2039/53, A61K2039/55516, A61K2039/572
View on Google Patents ↗

Quick answer

US 11911455 (HPV therapeutic nucleic acid vaccine) is held by Beijing Aeonvital Biomedicine Research Co., Ltd.. Status: granted. Granted Feb 27, 2024. Expires Feb 22, 2044 (18 years remaining) — relevant for patent-cliff and LOE planning.

Key facts

Grant date
Expiration
Claims
17
CPC classes
A61K, A61K2039/53, A61K2039/55516, A61K2039/572, A61K2039/575, A61K2039/70

More from Beijing Aeonvital Biomedicine Research Co., Ltd.

Related pharmaceutical patents in our USPTO index.

  1. US 11826405

    Neurotoxin compositions for use in treating headache

    Aeon Biopharma, Inc. · Expires Nov 23, 2043

    granted
  2. US 9901606

    Euglena lysate composition

    ALGAEON, INC. · Expires Feb 22, 2038

    granted
  3. US 9274109

    Gut flora-derived extracellular vesicles, and method for searching for a disease model, vaccine, and candidate drug and for diagnosis using the same

    Aeon Medix Inc. · Expires Feb 25, 2036

    granted
  4. US 9201072

    Gut flora-derived extracellular vesicles, and method for searching for a disease model, vaccine, and candidate drug and for diagnosis using the same

    Aeon Medix Inc. · Expires Nov 26, 2035

    granted
  5. US 9149542

    Microvesicles derived from cell protoplast and use thereof

    Aeon Medix Inc. · Expires Oct 1, 2035

    granted
  6. US 9084830

    Microvesicles derived from cell protoplast and use thereof

    Aeon Medix Inc. · Expires Jul 16, 2035

    granted
  7. US 8969653

    Extracellular vesicles derived from gram-positive bacteria, and use thereof

    Aeon Medix Inc. · Expires Feb 26, 2035

    granted

Frequently asked questions

What is US patent 11911455?

US 11911455 (HPV therapeutic nucleic acid vaccine) is held by Beijing Aeonvital Biomedicine Research Co., Ltd.. Status: granted. Granted Feb 27, 2024. Expires Feb 22, 2044 (18 years remaining) — relevant for patent-cliff and LOE planning.

Who owns US 11911455?

Beijing Aeonvital Biomedicine Research Co., Ltd. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 9 pharmaceutical patents for this assignee.

When does US 11911455 expire?

Our index shows an expiration date of Feb 22, 2044 (18 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.